ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,352,000 | -47.4% | 351,039 | -50.1% | 0.00% | -40.0% |
Q2 2022 | $4,474,000 | +51.3% | 703,478 | +10.4% | 0.01% | +66.7% |
Q1 2022 | $2,958,000 | -34.0% | 637,436 | -28.9% | 0.00% | -25.0% |
Q4 2021 | $4,485,000 | +945.5% | 896,972 | +2421.1% | 0.00% | – |
Q3 2021 | $429,000 | -17.5% | 35,579 | +77.9% | 0.00% | – |
Q4 2020 | $520,000 | -30.0% | 20,000 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $743,000 | -27.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,026,000 | +19.9% | 20,000 | -26.3% | 0.00% | 0.0% |
Q1 2020 | $856,000 | -86.6% | 27,125 | -74.6% | 0.00% | -85.7% |
Q4 2019 | $6,379,000 | +25.1% | 106,975 | -23.1% | 0.01% | +16.7% |
Q3 2019 | $5,099,000 | +56.5% | 139,090 | +98.6% | 0.01% | +20.0% |
Q2 2019 | $3,259,000 | +179.0% | 70,034 | +140.7% | 0.01% | +150.0% |
Q1 2019 | $1,168,000 | -39.4% | 29,100 | -30.5% | 0.00% | -33.3% |
Q4 2018 | $1,927,000 | -12.6% | 41,900 | -15.7% | 0.00% | 0.0% |
Q3 2018 | $2,205,000 | -23.0% | 49,697 | -32.0% | 0.00% | -25.0% |
Q2 2018 | $2,865,000 | +103.8% | 73,100 | +276.1% | 0.00% | +100.0% |
Q1 2018 | $1,406,000 | +104.4% | 19,434 | +85.9% | 0.00% | +100.0% |
Q4 2017 | $688,000 | +121.9% | 10,456 | -57.8% | 0.00% | 0.0% |
Q4 2016 | $310,000 | -57.2% | 24,796 | -52.6% | 0.00% | 0.0% |
Q3 2016 | $725,000 | +207.2% | 52,339 | +423.4% | 0.00% | – |
Q3 2015 | $236,000 | -82.5% | 10,000 | -39.4% | 0.00% | -100.0% |
Q2 2015 | $1,349,000 | +16.1% | 16,500 | +31.5% | 0.00% | 0.0% |
Q1 2015 | $1,162,000 | – | 12,547 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |